| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -2,887,709 | -4,237,751 | ||
| Foreign currency translation gain (loss) | 27,204 | -56,877 | ||
| Comprehensive loss | -2,860,505 | -4,294,628 | ||
| Earnings per share, basic | -0.65 | -1.06 | ||
| Earnings per share, diluted, total | -0.65 | -1.06 | ||
| Weighted average number of shares outstanding, basic | 4,443,262 | 3,981,992 | ||
| Weighted average number of shares outstanding, diluted, total | 4,443,262 | 3,981,992 | ||
MiNK Therapeutics, Inc. (INKT)
MiNK Therapeutics, Inc. (INKT)